跳至主要内容
临床试验/NCT04028024
NCT04028024Unknown不适用

Study on the Protective Effect of Inhibiting Systemic Inflammatory Response in Patients Undergoing Cardiac Surgery.

Shanghai Zhongshan Hospital0 个研究点目标入组 90 人开始时间: 2019年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
90
主要终点
postoperative delirium

研究概览

简要总结

The purpose of the study was to verify the protective effect of inhibiting systemic inflammatory response in patients undergoing cardiac surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • subject needs to have valve surgery
  • subject needs to have coronary artery bypass grafting surgery
  • subject needs to have artificial blood vessel replacement surgery
  • ASA(American Society of Anesthesiologists) score II~III
  • NYHA(New York Heart Association) II~III

排除标准

  • LVEF(left ventricular ejection fraction) <40% measured by echocardiogram
  • history of myocardial infarction within 1 month
  • history of serious pulmonary infection or endocarditis within 3 months
  • history of important surgery within 6 months

研究组 & 干预措施

inhibiting systemic inflammatory response

Other

Ulinastatin 5000U/kg in 20ml NS i.v. before occlusion of aorta

干预措施: Ulinastatin (Drug)

结局指标

主要结局

postoperative delirium

时间窗: 7 days postoperatively or discharge, whichever came first

the incidence of postoperative delirium

postoperative renal insufficiency

时间窗: 7 days postoperatively or discharge, whichever came first

the incidence of renal insufficiency

次要结局

未报告次要终点

研究者

发起方
Shanghai Zhongshan Hospital
申办方类型
Other
责任方
Sponsor

相似试验